GCTK - GlucoTrack Inc

GCTK - GlucoTrack Inc

https://glucotrack.com

Recent News

Powered by Alpha Vantage

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

GlobeNewswire • 1 month, 2 weeks ago • score: 0.27

Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot study Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot study ...

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? - GlucoTrack ( NASDAQ:GCTK )

Benzinga • 2 months, 3 weeks ago • score: 0.22

Glucotrack's device showed a 7.7% MARD, 99% data capture, and zero serious adverse events in a human trial. The device measured glucose from blood, not fluid, and had 92% values in the green zone per DTS Error Grid. Ready to turn the market's comeback into steady cash flow?

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

GlobeNewswire • 3 months ago • score: 0.18

1-for-60 reverse stock split to become effective as of the opening of trading on June ...

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Business Insider • 3 months ago • score: 0.18

1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes in Europe and Asia Pacific. The company is headquartered in Or Yehuda, Israel.

52W High

$3756.00

52W Low

$4.22

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.18

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.02

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.64

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

5.55%

Institutions (25–75% balanced)

0.81%

Shares Outstanding

899,410

Float

850,270

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

-20,000

EPS (TTM)

-2441.21

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-14.91%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—